Diverse by nature – experts by design
Cell & Gene therapies spread across a wide range of modalities. As the leading CDMO in this space, we are constantly investing and developing our extensive experience across this broad spectrum, including emerging new modalities, to provide you with the expertise you need for your therapy.
We provide a wide of range of services to suit your development, clinical and commercial manufacturing stage. Whether you wish to work on clinical, commercial manufacturing or on bringing your therapy from concept to patients, we can help you achieve your goals.
Customized Cell & Gene technologies for cGMP manufacturing
While we pride ourselves in being fully technology agnostic for our customers, our proprietary cell & gene therapy manufacturing technologies are always available to our customers, at any stage of development.
Our approach to develop and manufacture your therapy from concept to commercialization and beyond
Our New Product Introduction (NPI) and Lifecycle program, maps out your entire journey to commercialization. It accounts for each key milestone with checkpoints, to ensure you meet all required quality standards as your therapy progresses towards commercialization. The NPI program leverages our heritage and longstanding experience in establishing cGMP manufacturing standards. It combines both corporate and local quality standards customized for cell and gene therapies, to de-risk your journey to commercialization.
Lonza AAV suspension transient transfection platform to de-risk your path to clinic
Cocoon magnetic selection for consistent cellular starting material in cell therapy manufacture
When using a closed and automated manufacturing platform, is there an option to maintain...
Delivering an end-to-end industrialization roadmap for autologous cell therapy
The Cell and Gene Therapies Journey from Translation to GMP Production and Commercialization
Pre-developed assays for cell and gene therapies
Key Regulatory Considerations for Cell and Gene Therapy Products 2021
Cocoon® Platform Brochure
Lonza and Adva Biotechnology Ltd. Agree to Expand Availability and Use of Automated Bioreactors with...
More Sensitive Non-endotoxin Pyrogen Detection Now Possible with Lonza’s New PyroCell Monocyte...
By joining Lonza, you will get to work with some of the world’s top experts in the space, while developing advanced therapies with a potentially life-saving outcome.
Behnam Ahmadian Baghbaderani
Global Head of Process Development